Jiexiang Chen1,
Yong Cao2,
Li Tang4,
Yan Li2,
Xiaolan Yu3,
Jiyi Xia4
For correspondence:- Jiyi Xia Email: xiajiyi6600@163.com Tel:+868303160048
Accepted: 20 June 2019 Published: 28 July 2019
Citation: Chen J, Cao Y, Tang L, Li Y, Yu X, Xia J. Wogonoside exerts potential anti-tumor activity against bladder cancer in vivo and in vitro via regulation of GSK-3β/ERK/AKT signaling pathway. Trop J Pharm Res 2019; 18(7):1385-1390 doi: 10.4314/tjpr.v18i7.3
© 2019 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Archives
News Updates